Global Ophthalmic Medicine Market 2020 Size, Market Share, Key Players, Segmentation Development and Forecast by 2025

The MarketWatch News Department was not involved in the creation of this content.

Dec 02, 2020 (CDN Newswire via Comtex) —
The report entitled Global Ophthalmic Medicine Market 2020 by Manufacturers, Type and Application, Forecast to 2025 compiled by MarketQuest.biz presents a new market research analysis that offers a detailed evaluation of the business vertical and a brief overview of the industry segments. The report includes an elemental introduction to the industry, market overview, scope, and product specification. The report aims to target the major images related to market growth, major types, and various end users applicable, regional analysis, productivity structure, current, and future market situation. The report provides a determined perception of the popular market situation that also covers market size in terms of value and volume. Important segment classification of this market includes global Ophthalmic Medicine market-leading players, major geographical regions, product types, and applications.

The report describes the growth of the market such as manufacturers, market size, types, applications, and regions. The report highlights key factors driving and restraining market growth. The research portrays previous and forecasts information in the form of graphical representation. Factors that are encouraging the growth of a specific type of product category and factors that are motivating the status of the market are further included in this report. A comprehensive study of the market is done to recognize the several applications of the features of products and usage.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT:https://www.marketquest.biz/sample-request/20234

The major players who are leading the market throughout the globe are: Novaliq, Mentholatum, Chengdu Kanghong Pharmaceutical Group, Shenyang Xingqi Pharmaceutical Co.,Ltd., Alcon NV, Zhejiang Shapuaisi Pharmaceutical, Bausch Health, Santen Pharmaceutica

Moreover, the report concentrates on global higher leading business players with their details such as company profiles, product picture and specifications, sales, market share, and association information. Additionally, developing strategies and programs are addressed as well as manufacturing methods and cost formations are included. The research contains an analysis of the strategies of major competitors. Elements such as production capacity, price, demand, supply chain/logistics, profit/loss, material parameters/specifications, and the growth factor have been reviewed in the report.

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including: Anti-fatigue and Dryness, Cataract, Anti-infective

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share, and growth rate of each type, primarily split into: Eye Drops, Eye Ointment, Gelling Agent, Tablet, Injection

Keeping the regional landscape of the global Ophthalmic Medicine market in mind, this industry is segmented into: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast

Read more

Sports Medicine Market Analysis by Applications, End-Users, Top Companies, Future Growth Opportunities, Product Type, Global Forecast To 2020

The MarketWatch News Department was not involved in the creation of this content.

Japan, Japan, Wed, 02 Dec 2020 14:20:31 / Comserve Inc. / — Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

The sports medicine market comprises products and devices used by professional or non-professional athletes or sportspersons to prevent and protect themselves from injuries as well as devices that enhance performance. The sports medicine products play an important role in the rehabilitation, recovery, protection, endurance, and monitoring of athletes while playing sports. Over the years, the sports medicine market has witnessed various technological advancements made to ensure and provide better recovery and rehabilitative measures for injuries caused during sports or physical activities.

These advancements have led to the development of new products and therapies to treat sports injuries. Various market players are focusing on the introduction of newer products and treatment options for sports injuries. A number of key players are competing to secure larger shares of the market by launching new products. Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), DePuy Synthes Companies (U.S.), Stryker Corporation (U.S.), and CONMED Corporation (U.S.) are the top five players of this market

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-61031

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

In 2015, the body reconstruction & repair products segment is expected to account for the largest share of the global sports medicine market, by product, while the knee injuries segment is expected to account for the largest share of the sports medicine market, by application.

In 2015, North America is expected to account for the largest share of the global sports medicine market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). In the coming years, the sports medicine market is expected to witness the highest growth rate in the Asia-Pacific region, with emphasis on India, China, and Japan. The entry of international players, increasing government initiatives, and rising awareness regarding sports medicine in emerging nations like India and China are expected to drive the market in these regions.

The sports medicine market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various growth strategies (agreements, partnerships, joint ventures, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

“The Final Report will cover the impact analysis of COVID-19 on this industry (Global And Regional Market).”

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market

Read more

Regenerative Medicine Market measure with Report In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast till 2026

The MarketWatch News Department was not involved in the creation of this content.

Dec 02, 2020 (Market Insight Reports) —
The latest report on ‘Regenerative Medicine market’ collated by Market Study Report, LLC, delivers facts and numbers regarding the market size, geographical landscape and profit forecast of the ‘Regenerative Medicine market’. In addition, the report focuses on major obstacles and the latest growth plans adopted by leading companies in this business.

Request a sample Report of Regenerative Medicine Market at: https://www.marketstudyreport.com/request-a-sample/1695290?utm_source=marketwatch&utm_medium=RV

The Regenerative Medicine Market is anticipated to reach over USD 79.23 billion by 2026 according to a new research. In 2017, the cell therapy dominated the global Regenerative Medicine market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue in 2017.

The regenerative medicine market is primarily driven by the increasing number of individuals suffering from cancer, rising need to monitor and treating these chronic diseases in the limited time. Furthermore, stringent government policies, proper reimbursement policies, and increasing government healthcare expenditure for developing healthcare infrastructure to also boost the market growth in coming years. Also, rising number of organ transplantation, and increasing number of products in pipeline that are waiting for approval create major opportunity for the regenerative medicines in the coming years. However, some of the ethical and religious concerns for the use of stem cells, and lack of proper regulatory for the approval of various drugs would impede the market growth during the forecast period.

Enquiry about Regenerative Medicine market report before Buying at: https://www.marketstudyreport.com/enquiry-before-buying/1695290?utm_source=marketwatch&utm_medium=RV

North America generated the highest revenue in the Regenerative Medicine market in 2017, and is expected to be the leading region globally during the forecast period. Increasing number of patients suffering from chronic diseases, improved healthcare infrastructure and health facilities, accessibility of healthcare facilities, are the primary factors driving the market growth in this region. While, Asia Pacific to be the fastest growing region in the coming years. The growth in this region is majorly attributed to the developing healthcare infrastructure of the countries like India, & China, and rising awareness for the use of regenerative medicines as an effective treatment option for chronic diseases.

Regenerative medicine is a branch of medicine that regrows, and repairs the damaged cells in the human body. These medicines include the use of stem cells, tissue engineering, that further helps in developing new organ that function smoothly. These medicines have the caliber of developing an entire organ as these cells are multipotent. The cells are majorly isolated from bone marrow, and umbilical cord blood.

Purchase full report of Regenerative Medicine market at: https://www.marketstudyreport.com/securecheckout/paymenta/1695290?utm_source=marketwatch&utm_medium=RV?msfpaycode=sumsf

The key players operating in the Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Regenerative Medicine Market share

Read more

Fitness App Market 2020 provides an in-depth insight of Sales and Trends Forecast to 2026

The MarketWatch News Department was not involved in the creation of this content.

Dec 01, 2020 (AmericaNewsHour) —
The Global fitness app market size is anticipated to reach over USD 14.7 billion by 2026, according to a new study published by Polaris Market Research. In 2017, the fitness and activity tracking segment dominated the market, in terms of revenue. North America is expected to be the leading contributor to the global fitness app industry during the forecast period.
A significant increase in the obese population, changing lifestyles, and increasing health concerns primarily drive the market growth. Other driving factors include increasing occurrence of diseases associated with obesity, increasing disposable income, and increasing awareness regarding health and nutrition. The increase in obesity related diseases such as diabetes and hypertension along with sedentary lifestyles of consumers further propel the market growth.

Download Sample of This Strategic Report:- https://www.kennethresearch.com/sample-request-10070828

The number of memberships for health clubs and gyms has increased significantly over the years, further promoting the growth of fitness app industry. Increasing demand in developing nations, increasing penetration of mobile devices, and availability of high-speed internet services is expected provide numerous growth opportunities to the fitness app industry players during the forecast period.

A few major fitness apps available in the market include Runtastic Results, Calorie Counter & Diet Tracker, and Sweat, Kayla Itsines Fitness among others. Runtastic Results: Workout & Strength Training is offered by the Austrian company Runtastic. As part of the primary marketing strategy in fitness app industry, the company offers a wide range of portfolio with 20 different mobile apps running on all platforms. Runtastic was bought by Adidas in 2015 to increase its market share in the global fitness market industry. Sweat: Kayla Itsines Fitness is an app offered by The Bikini Body Training Company. This app provides nutrition recommendations and a series of aerobic exercises in the Bikini Body Guide (BBG) to practice at home.

In regards with the global fitness app market share, North America was in the forefront followed by Asia Pacific and Europe. The increasing population in the region coupled with high disposable income drives the market growth. The sedentary lifestyle of consumers in the region has encouraged them to adopt fitness apps to stay healthy and acquire proper nutrition. Asia-Pacific is expected to grow at the highest rate during the forecast period. Increasing disposable incomes in developing countries of this region, rising awareness and increasing health consciousness, growing presence of fitness centres, and growing penetration of smartphones further foster the growth of the fitness app industry in this region.

The key companies profiled in the report fitness app market analysis includes MyFitnessPal Inc., Dom and Tom Tom, Motorola Mobility LLC, Grandapps, Fitbit, Azumio, WillowTree, Inc., ASICS, Under Armour, and Appster among others. These companies launch new products and collaborate with other market leaders bringing innovation to meet the increasing demand of consumers.

Polaris Market Research has segmented the global fitness app market on the basis of type, platform, deployment, gender, and

Read more

Nuclear Medicine Market Research Report by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19 – Press Release

New York, Dec. 01, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Nuclear Medicine Market Research Report by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p05993422/?utm_source=GNW

The Global Nuclear Medicine Market is expected to grow from USD 3,812.67 Million in 2019 to USD 5,701.38 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.93%.

Market Segmentation & Coverage:
This research report categorizes the Nuclear Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Nuclear Medicine Market studied across Diagnostic Products and Therapeutic Products. The Diagnostic Products further studied across PET and SPECT. The Therapeutic Products further studied across Alpha Emitters, Beta Emitters, and Brachytherapy.

Based on Application, the Nuclear Medicine Market studied across Bone Metastasis, Cardiology, Endocrine Tumor, Lymphoma, Oncology, and Thyroid.

Based on Geography, the Nuclear Medicine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Nuclear Medicine Market including Australian Nuclear Science & Technology Organization (ANSTO), Bracco Imaging S.p.A, Curium Pharma, Eckert & Ziegler, Eczacibasi-Monrol, GE Healthcare, Jubilant Pharma. LLC, Lantheus Medical Imaging, Inc., Mallinckrodt, Nordion (Canada) Inc., NTP Radioisotopes SOC Ltd., and The Institute for Radioelements (IRE – IRE ELiT).

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nuclear Medicine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces,

Read more

Global Ayurvedic Medicine Market Size by Regional Industry Growth, Statistics & Forecast by 2025

The MarketWatch News Department was not involved in the creation of this content.

Nov 26, 2020 (Market Insight Reports) —
Selbyville, Delaware, MarketStudyReport.com offers report on Global Ayurvedic Medicine Market that evaluates industry growth trends through historical data and estimates prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2020 – 2025.

The global Ayurvedic Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.4% in the forecast period of 2020 to 2025 and will expected to reach 7331.5 million by 2025, from 4754.3 million in 2019.

The Ayurvedic Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Request a sample copy of this report at:

https://www.marketstudyreport.com/request-a-sample/2468922/?utm_source=Marketwatch.com&utm_medium=SK

Main Objectives of this Global Ayurvedic Medicine Marketstudy:

To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the Global Ayurvedic Medicine Market.

To strategically analyze the Micro markets with respect to individual growth trends, Prospects, and Contributions to the total market.

To analyze opportunities in the overall Global Ayurvedic Medicine Market for stakeholders by identifying the high growth segments.

To describe and forecast the overall Global Ayurvedic Medicine Market, in terms of value, segmented based on type, and application.

To forecast the market size for various segments, by key region.

The Global Ayurvedic Medicine Market spans across five major geographies: North America, Latin America, Europe, Asia-Pacific and the Middle East and Africa.

To analyze opportunities in the overall Global Ayurvedic Medicine Market for stakeholders by identifying the high growth segments.

To profile key players and analyze their Market ranking in terms of revenues and core competencies and provide details of the competitive landscape for the Global Ayurvedic Medicine Market leaders.

To analyze growth strategies such as Contracts, Mergers and Acquisitions, Product launches and Developments, and Research and Development in the overall Global Ayurvedic Medicine Market.

Segmentation of Global Ayurvedic Medicine Market:

Ayurvedic Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ayurvedic Medicine market has been segmented into:

Health Care

Oral Care

Hair Care

Skin Care

Others

By Application, Ayurvedic Medicine has been segmented into:

Women

Men

Kids

key Companies covered:

Patanjali Ayurved Limited

Vicco Laboratories

Himalaya Drug

Dabur

Shahnaz Husain Group

Emami Group

Charak Pharma

Baidyanalh

Maharishi Ayurveda

Amrutanjan Healthcare

Botique

Natreon

Herbal Hills

Basic Ayurveda

Main reasons for the purchase:

To obtain insightful analysis of the Global Ayurvedic Medicine Market and a comprehensive understanding of

Read more

Trigeminal Neuralgia Treatment Medicine Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 25, 2020 (The Expresswire) —
The report “Trigeminal Neuralgia Treatment Medicine Market” in Global to 2026 – Market Scope, Development, and Predictions offers the most up-to-date industry information on the actual market situation, and future outlook for vision frames and mountings in worldwide.

The research includes historic data from 2020 and forecasts until 2026 which makes the report a valuable resource for industry executives, presentation, sales and product managers, consultants, analysts, and other people looking for key industry data in a readily available document with clearly presented tables and Figures.

Request a sample copy of the report – https://www.absolutereports.com/enquiry/request-sample/16562110

Trigeminal Neuralgia Treatment Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Trigeminal Neuralgia Treatment Medicine business, the date to enter into the Trigeminal Neuralgia Treatment Medicine market, Trigeminal Neuralgia Treatment Medicine product introduction, recent developments, etc.

The Following Manufacturers Are Covered in This Report:

● Novartis Pharma AG ● Sihuan Pharma ● Wuhan Humanwell ● Raybow Pharma ● Jinan Jinda Pharmaceutical ● Sinopharm ● Jiangsu Tohope Pharma ● Yabang Medicine ● Taro ● Torrent Pharmas ● Wockhardt Bio AG ● Apotex Inc ● Teva Pharmas ● Zydus Pharms ● Unique Pharm ● Rubicon ● Sun Pharma Inds ● Glenmark Pharms Ltd ● Breckenride Pharm ● Amneal Pharms

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT – REQUEST SAMPLE

Trigeminal Neuralgia Treatment Medicine Market Breakdown Data by Type

● Carbamazepine ● Oxcarbazepine ● Others

Trigeminal Neuralgia Treatment Medicine Market Data by Application

● Hospitals ● Clinic ● Others

Inquire Or Share Your Questions If Any Before The Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/16562110

Geographic Segmentation

The report offers exhaustive assessment of different region-wise and country-wise Breast Localization Needles markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Breast Localization Needles market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Detailed TOC of Global Trigeminal Neuralgia Treatment Medicine Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

1 Trigeminal Neuralgia Treatment Medicine Market Overview

1.1 Product Overview and Scope of Trigeminal Neuralgia Treatment Medicine

1.2 Trigeminal Neuralgia Treatment Medicine Segment by Type

1.2.1 Global Trigeminal Neuralgia

Read more

Sports Medicine Device Market Insights (2020 to 2025) – Analysis and Forecast for the Global and Chinese Markets – Press Release

Dublin, Nov. 02, 2020 (GLOBE NEWSWIRE) — The “Sports Medicine Device Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type” report has been added to ResearchAndMarkets.com’s offering.

This report is a professional and in-depth study on the current state of the global Sports Medicine Device market with a focus on the Chinese market. The report provides key statistics on market of Sports Medicine Device. It is a valuable source of guidance and direction for companies and individuals interested in Sports Medicine Device industry.

Key points of Sports Medicine Device Market Report:
1. The report provides a basic overview of Sports Medicine Device industry including: definition, applications and manufacturing technology.
2. The report explores Global and Chinese major players in Sports Medicine Device market. In this part, the report presents the company profile, product specifications, capacity, production value, and 2015-2020 market shares for each company.
3. The report depicts the global and Chinese total Sports Medicine Device market including: capacity, production, production value, cost/profit, supply/demand and Chinese import/export, by statistical analysis.
4. The global Sports Medicine Device market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5. The report then estimates 2020-2025 development trends, analyse upstream raw materials, downstream demand, and current market dynamics of Sports Medicine Device market.
6. The report makes some important proposals for a new project of Sports Medicine Device Industry before evaluating its feasibility.
7. Overall, the report provides an in-depth insight of 2015-2025 global and Chinese Sports Medicine Device market covering all important parameters.

Main Parameters for this report:

Type Segment:

Companies Covered:

  • Arthrex
  • Smith & Nephew
  • Stryker
  • Depuy Synthes/Johnson & Johnson
  • Zimmer Biomet
  • Karl Storz
  • Conmed
  • Wright
  • Medshape
  • Valeris
  • Rog
  • Aceosteo
  • Asco Medical
  • Atlas Surgical
  • Auxein
  • Biotek
  • Bonetech Medisys
  • CHM
  • Egifix
  • Forerunner
  • Fxorthopedi
  • Gesco Medical
  • GPC Medical Ltd
  • Green Surgical
  • Griphorto
  • Hardik International
  • HIBS
  • Innomed Solutions
  • Jeil Medical
  • Jiangsu Bai De Medical Instrument
  • Marapole
  • Matrix
  • Medgal
  • Microport
  • Miraclus
  • Narang
  • Naton Group
  • Nebula

Key Topics Covered:

1.: Introduction of Sports Medicine Device Industry
1.1 Brief Introduction of Sports Medicine Device
1.2 Development of Sports Medicine Device Industry
1.3 Status of Sports Medicine Device Industry

2.: Manufacturing Technology of Sports Medicine Device
2.1 Development of Sports Medicine Device Manufacturing Technology
2.2 Analysis of Sports Medicine Device Manufacturing Technology
2.3 Trends of Sports Medicine Device Manufacturing Technology

3.: Analysis of Global Key Manufacturers
3.1 Arthrex
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 Capacity Production Price Cost Production Value
3.1.4 Contact Information
3.2 Smith & Nephew
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 Capacity Production Price Cost Production Value
3.2.4 Contact Information
3.3 Stryker
3.3.1 Company Profile
3.3.2 Product Information
3.3.3 Capacity Production Price Cost Production Value
3.3.4 Contact Information
3.4 Depuy Synthes/Johnson & Johnson
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 Capacity Production Price Cost Production Value
3.4.4 Contact Information
3.5 Zimmer Biomet
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 Capacity Production Price Cost Production Value
3.5.4 Contact Information
3.6 Karl

Read more

Asia Pacific Laser Therapy Market Forecast to 2027

The Asia Pacific laser therapy market is expected to reach US$ 768. 52 million by 2027 from US$ 348. 67 million in 2019; it is estimated to grow with a CAGR of 10. 5% from 2020 to 2027. The laser therapy market in Asia Pacific grows substantially due to growing medical applications of laser therapy and technological developments in laser therapies.

New York, Oct. 29, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Asia Pacific Laser Therapy Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type ; Application ; End User, and Geography” – https://www.reportlinker.com/p05978827/?utm_source=GNW
However, the high prices of laser therapy and devices hinder the growth of the market.

Laser therapy, a non-invasive medical procedure, uses the light of a specific wavelength to treat various diseases.This procedure is used to remove tumors or abnormal cell growth, perform hair and skin treatments, remove kidney stones, and repair a detached retina.

In medicine, the laser allows surgeons to work at a high level of precision by focusing on a definite area, and this process creates lesser damage than the traditional methods of surgery. The process of laser therapy is however costly and may require repetitive visits to the surgeon.

Various medical device manufacturers and start-ups introduce the latest technologies in the market and the availability of various advanced products allows medical professionals to improve patients’ health by enhancing their treatment efficiency. For instance, in February 2020, IRIDEX Corporation, a manufacturer of ophthalmic laser-based medical products, launched an upgraded second-generation version of MicroPulse P3 device to treat glaucoma, and the upgrades made to the device are expected to substantially reduce intraocular pressure suitable for glaucoma patients without incisions.

Furthermore, in June 2020, Cynosure launched Elite iQ Aesthetic Workstation for laser hair removal and skin revitalization in Australia, allowing faster treatment with higher max energy compared with previous generation devices.Moreover, in February 2019, GakSung introduced the Laser Queen, a low-level laser and LED therapy known as photon light therapy, in India to treat a variety of conditions.

Thus, the consistent technological developments through the launch of new products in the market augment the growth of the laser therapy market in Asia Pacific.

China, Japan, India, Australia, and South Korea are the most affected countries due to the increasing number of COVID-19 cases and the associated deaths.Manufacturers and suppliers of medical devices are shifting their focus from regular laser therapy devices to the development and supply of COVID-19 essentials and medical devices used for respiratory issues.

This scenario adversely impacts the dermatology & cosmetic and minimally invasive therapies performed with laser devices.

Based on type, in 2019, the diode segment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period.This segment witnesses a lucrative growth owing to its rapid adoption in photodynamic treatments and aesthetic procedures.

Additionally, the diode laser is used for processes such as incision, hemostasis, and coagulation. Moreover, the implementation of diode laser causes minimal

Read more

Europe Anti-Viral Therapies Market Forecast to 2027

The Europe anti-viral therapies market is expected to reach US$ 21,122. 66 million by 2027 from US$ 11,401. 67 million in 2019; it is estimated to grow at a CAGR of 8. 1% during 2020–2027. The market is growth is primarily attributed to the increasing R&D expenditures in pharmaceutical companies and rising government support for research activities and clinical trials in Europe.

New York, Oct. 28, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Europe Anti-Viral Therapies Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type, Mechanism of Action, and Application, and Country” – https://www.reportlinker.com/p05978841/?utm_source=GNW
Additionally, strong pipeline of anti-viral drugs, and growing emphasis on launching anti-viral agents are likely to fuel the growth of the Europe anti-viral therapies market during the forecast period.

High cost of drug development is a key factor restraining the growth of the market.
Antiviral therapy is one of the most exciting branches of virology. These therapies are based on several strategies—direct-acting antivirals target viral proteins, enzymes, or nucleic acids; passive antibodies neutralize circulating viruses; and several other antivirals target cellular proteins or processes essential for viral replication.

Research and development (R&D) is an essential part of any business.Pharmaceutical companies focus on R&D to introduce new drugs with enhanced medical and commercial potential.

These companies invest majorly in R&D activities with an aim to deliver high-quality and innovative products in the market. As per the Association of the British Pharmaceutical Industry Pharmaceutical R&D expenditures grew by >11% in the UK in 2001, reaching an estimated US$ 5.23 billion. Johnson & Johnson, and Pfizer are among the top 10 leading R&D investing companies. The UK’s relative stability compared to the rest of Europe as a base for investment to an increase in R&D activity there by the three largest pharmaceutical investors. AstraZeneca, GlaxoSmithKline, and Pfizer collectively signify over 70% of total R&D spending in the UK, while other manufacturers with a significant presence in the country include Merck, Sharp & Dohme, Organon, Eli Lilly, and Novartis. Additionally, the pharma companies in the Germany are highly engaged in R&D activities.

Europe has witnessed exponential growth in the count of COVID-19 cases.Spain, Italy, Germany, France, and the UK are among the most affected European countries.

Growing research activities to develop treatment against corona virus is likely to favor the growth of the market in this region.In June 2020, the scientists from the University of Oxford tested existing drugs as therapies against this novel virus.

Further, the European Commission in July authorized the anti-viral drug Remdesivir for its use in the treatment of COVID-19 patients, making it the first approved drug in the European Union for the treatment.

In 2019, the branded drugs segment accounted for a larger share of the Europe antiviral therapies market.The branded antiviral drugs are more trusted than the generic drugs.

Further, robust research and development activities, increasing number of drug discoveries, and rising number of patents for drugs are the factors supporting the growth of this segment.

A

Read more